Dismissed on Oct 13, 2022
Endo is in post-confirmation administration: its plan was confirmed on March 22, 2024 and became effective on April 23, 2024, with Patrick J. Bartels, Jr. serving as Plan Administrator for the Remaining Debtors. The latest report for the main case, covering the quarter ended June 30, 2026, records no current-quarter transfers and anticipates an application for a final decree by September 30, 2026. June 2026 post-confirmation reportDkt. 397
Updated Sep 5, 10:29 AM ET
Motion to Disallow Claims / Plan Administrators Tenth Omnibus Objection to Certain (I) Amended Claims, (II) No Liability Claims, (III) Modified Amount Claims, and (IV) Reclassified Class 4(D) Ranitidine Claims filed by Brian P Maloney on behalf of Patrick J. Bartels, Jr., Plan Administrator for the Remaining Debtors.
Dkt. 400 · Aug 18, 2026
Order Signed on 8/4/2026 Establishing an Additional Endo Opioid Personal Injury Sub-Qualified Settlement Fund. (Related Doc # 389)
Dkt. 399 · Aug 4, 2026
Chapter 11 Post-Confirmation Report for Case Number 22-22617 for the Quarter Ending: 06/30/2026 Filed by Catherine V. LoTempio on behalf of Patrick J. Bartels, Jr., Plan Administrator for the Remaining Debtors.
Dkt. 398 · Aug 1, 2026
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.